Noteworthy impacts of COVID-19 pandemic on cancer screening: A systematic review

Fundamental Research, Journal Year: 2024, Volume and Issue: 4(3), P. 484 - 494

Published: Feb. 8, 2024

The sudden onset of the coronavirus disease 2019 (COVID-19) in January 2020 has affected essential global health services. Cancer-screening services that can reduce cancer mortality are strongly affected. However, specific role COVID-19 screening is not fully understood. This study aimed to assess efficiency programs before and during pandemic promote potential cancer-screening strategies for next pandemic. Electronic searches PubMed, Embase, Web Science, manual were performed between 1, March 2023. Cohort studies reported number participants who underwent included. methodological quality included was assessed using Newcastle-Ottawa Scale. Differences rates estimated incidence rate ratio (IRR). Fifty-five cohort this meta-analysis. colorectal invasive methods (Pooled IRR=0.52, 95% CI: 0.42 0.65, p<0.01), cervical IRR=0.56, 0.47 0.67, breast IRR=0.57, 0.49 0.66, p<0.01) prostate IRR=0.71, 0.56 0.90, significantly lower than those lung IRR=0.77, 0.58 1.03, p=0.08) noninvasive IRR=0.74, 0.50 1.09, p=0.13) reduced with no statistical differences. subgroup analyses revealed reduction varied across economies. Our results suggest had a noteworthy impact on colorectal, cervical, breast, screening. Developing innovative technologies important post-COVID-19 era prepare

Language: Английский

---

Beyond liquid biopsy: Toward non-invasive assays for distanced cancer diagnostics in pandemics

Biosensors and Bioelectronics, Journal Year: 2021, Volume and Issue: 196, P. 113698 - 113698

Published: Oct. 13, 2021

Language: Английский

---

Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer

Cancer Discovery, Journal Year: 2021, Volume and Issue: 12(2), P. 303 - 330

Published: Dec. 10, 2021

The ongoing coronavirus disease 2019 (COVID-19) pandemic has left patients with current or past history of cancer facing disparate consequences at every stage the trajectory. This comprehensive review offers a landscape analysis state literature on COVID-19 and cancer, including immune response to COVID-19, risk factors for severe disease, impact anticancer therapies. We also latest data treatment vaccination safety efficacy in as well care, urgent need rapid evidence generation real-world study designs. SIGNIFICANCE: Patients have faced journey due pandemic. field regarding cancer. cover response, implications care delivery. Overall, this provides an in-depth summary key issues during unprecedented health crisis.

Language: Английский

---

The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series

ESMO Open, Journal Year: 2021, Volume and Issue: 7(1), P. 100374 - 100374

Published: Dec. 17, 2021

•Risk of distress/burnout amongst oncology professionals continues to worsen since COVID-19 despite improved job performance.•Female and younger (≤40 years old) colleagues continue be at higher risk poor well-being feeling burnout.•Job demands have increased, with nearly half now overwhelmed workload.•Concerns regarding career development/training, security, international fellowship opportunities remain high.•A quarter reported considering changing their career, including leaving the profession. BackgroundCOVID-19 has had a significant impact on performance globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration set out investigate monitor in relation work, lifestyle support factors 1 year start pandemic.MethodsAn online, anonymous survey was conducted February/March 2021 (Survey III). Key outcome variables included or distress (expanded Well-Being Index), burnout (single item from expanded COVID-19. Longitudinal analysis responses series three surveys carried out, resources questions were interrogated. SPSS V.26.0/V.27.0 GraphPad Prism V9.0 used statistical analyses.ResultsResponses 1269 participants 104 countries analysed Survey III: 55% (n = 699/1269) female, 54% 686/1269) >40 years, 69% 852/1230) white ethnicity. There an increased 464/1169, 40%) 660/1169, 57%) compared I (25% 38% respectively, P < 0.0001), performance. Compared initial period pandemic, more report workload (45% versus 29%, 0.0001). concerns about negative pandemic development/training (43%), security (37%). (76%). Alarmingly, 25% 266/1086) are future 100/266) contemplating profession.ConclusionOncology face demands. is concern potential attrition workforce. National stakeholders must act immediately work closely draw up future-proof recovery plans. pandemic. An analyses. Responses

Language: Английский

---

A rapid review of COVID-19’s global impact on breast cancer screening participation rates and volumes from January to December 2020

eLife, Journal Year: 2023, Volume and Issue: 12

Published: Sept. 12, 2023

COVID-19 has strained population breast mammography screening programs that aim to diagnose and treat cancers earlier. As the pandemic affected countries differently, we aimed quantify changes in volume uptake during first year of . We systematically searched Medline, World Health Organization (WHO) database, governmental databases. Studies covering January 2020 March 2022 were included. extracted analyzed data regarding study methodology, volume, uptake. To assess for risk bias, used Joanna Briggs Institute (JBI) Critical Appraisal Tool. Twenty-six cross-sectional descriptive studies (focusing on 13 countries/nations) included out 935 independent records. Reductions rates observed among eight countries. Changes participation five nations with national population-based ranged from -13 -31%. Among two limited programs, decline -61 -41%. Within USA, volumes varied ranging +18 -39%, suggestion differences by insurance status (HMO, Medicare, low-income programs). Almost all had high bias due insufficient statistical analysis confounding factors. The extent COVID-19-induced reduction differed region suggested potential healthcare setting (e.g., health vs. private healthcare). Recovery efforts should monitor access early diagnosis determine whether prevention services need strengthening increase coverage disadvantaged groups reduce disparities.

Language: Английский

---

Qualitative evaluation of a codesigned faith-based intervention for Muslim women in Scotland to encourage uptake of breast, colorectal and cervical cancer screening

BMJ Open, Journal Year: 2022, Volume and Issue: 12(5), P. e058739 - e058739

Published: May 1, 2022

This pilot study aimed to evaluate the acceptability of a codesigned, culturally tailored, faith-based online intervention increase uptake breast, colorectal and cervical screening in Scottish Muslim women. The was codesigned with women (n=10) underpinned by reframe, reprioritise reform model behaviour change wheel.The conducted online, using Zoom, due COVID-19 pandemic.Participants (n=18) taking part subsequently its evaluation, were residing Scotland, recruited through purposive snowball sampling from mosque community organisations. Participants aged between 25 years 54 Asian Arab ethnicity.The study's included (1) peer-led discussion barriers screening, (2) health education session led healthcare provider, (3) videos women's experiences cancer or (4) religious perspective on delivered female scholar (alimah). twice March 2021, followed 1 week later two focus groups, consisting same participants, respectively, discuss participants' intervention. Focus group transcripts analysed thematically.Participants accepted content delivery positive about their experience reported knowledge had increased shared views towards screening. They valued multidimensional intervention, appreciated perspective, particular liked personal stories input provider.Participatory community-centred approaches can play an important role tackling inequalities Despite limitations, showed potential positively received participants. Feasibility testing is needed investigate effectiveness larger scale full trial.

Language: Английский

---

The impact of the COVID-19 pandemic on Italian population-based cancer screening activities and test coverage: Results from national cross-sectional repeated surveys in 2020

eLife, Journal Year: 2023, Volume and Issue: 12

Published: Feb. 3, 2023

Background: In Italy, regions have the mandate to implement population-based screening programs for breast, cervical, and colorectal cancer. From March May 2020, a severe lockdown was imposed due COVID-19 pandemic by Italian Ministry of Health, with suspension programs. This paper describes impact on activities test coverage in 2020 overall socioeconomic characteristics. Methods: The regional number subjects invited tests performed were compared those 2019. Invitation examination also calculated. PASSI surveillance system, through telephone interviews, collects information about uptake provider (public private opportunistic). Test last year computed educational attainment, perceived economic difficulties, citizenship. Results: A reduction performed, differences between periods geographical macro areas, observed vs. larger than that invitation all second half trend showed decrease areas Compared pre-pandemic period, there greater difference according level education odds having had never been screened or not being up date tests. Conclusions: ongoing emergency caused an important delay activities. increased preexisting individual inequalities access. opportunistic did mitigate pandemic. Funding: study partially supported Health – Ricerca Corrente Annual Program 2023 Emilian Region DGR 839/22.

Language: Английский

---

Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in the United Kingdom and the Republic of Ireland – a scoping review

British Journal of Cancer, Journal Year: 2024, Volume and Issue: 131(4), P. 619 - 626

Published: May 4, 2024

The COVID-19 pandemic brought unplanned service disruption for breast cancer diagnostic, treatment and support services. This scoping review describes these changes their impact in the UK Republic of Ireland based on studies published between January 2020 August 2023. Thirty-four 569 papers were included. Data extracted results thematically organized. Findings include fewer new cases; stage shift (fewer early- more late-stage disease); to healthcare organization, screening treatment. Examples are accepting referrals, applying stricter referral criteria relying virtual consultations multi-disciplinary meetings. Screening programs paused during before enacting risk-based phased restarts with longer appointment times accommodate reduced staffing numbers enhanced infection-control regimes. Treatments shifted from predominantly conventional hypofractionated radiotherapy, surgical procedures increased use bridging endocrine therapy. long-term such unknown so definitive guidelines future emergencies not yet available. Cancer registries, large sample sizes population coverage, well placed monitor survival despite difficulties obtaining staging diagnosis because surgery pathological assessments delayed. Multisite longitudinal can also provide guidance disaster preparedness.

Language: Английский

---

Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic

The Oncologist, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 26, 2024

Abstract Background As an extended analysis of the COVID-DELAY study, we aimed to assess impact COVID-19 pandemic on diagnosis, staging, and survival outcomes among patients with colorectal cancer (CRC) diagnosis performed from 2019 2022. Methods All consecutive newly diagnosed CRC referred 11 Italian Oncology Departments between March December 2019, 2020, 2021, 2022 were enrolled. Access rate, demographics, diagnostic-therapeutic temporal intervals, first-line progression-free (PFS) OS metastatic assessed. Results Compared (n = 690), initial global reduction in new cases 2020 564, –18.3%) was observed, followed by a progressive increase diagnoses 2021 748, + 8.4%) 756, 9.6%); higher rate TNM stage IV tumors (35.4%) (31.0%) compared (29.6%), normalization (26.4%) (P &lt; .001). Not clinically relevant differences histological first oncological examination, cytohistological systemic treatment start, appointment start radiological assessment 2021-2022 years found. After propensity score matching according year median significantly worse (27.6 vs 24.8 not reached 38.9 months, respectively) Concordantly, PFS each passing year: 13.0 11.1 9.2 7.2 months 2022, respectively .00027). Conclusions A as well stages at The might have affected some time intervals 2020. Significantly, pre-pandemic phase, independently associated disease.

Language: Английский

---

Inequalities in colorectal cancer screening uptake in Wales: an examination of the impact of the temporary suspension of the screening programme during the COVID-19 pandemic

BMC Public Health, Journal Year: 2023, Volume and Issue: 23(1)

Published: March 22, 2023

Abstract Background Response to the early stages of COVID-19 pandemic resulted in temporary disruption cancer screening UK, and strong public messaging stay safe protect NHS capacity. Following reintroduction services, we explored impact on inequalities uptake Bowel Screening Wales (BSW) programme identify groups who may benefit from tailored interventions. Methods Records within BSW were linked electronic health records (EHR) administrative data Secured Anonymised Information Linkage (SAIL) Databank. Ethnic group was obtained a method available SAIL. We examined for first 3 months invitations (August October) following 2020, compared same period preceding years. Uptake measured across 6 month follow-up period. Logistic models conducted analyse variations by sex, age group, income deprivation quintile, urban/rural location, ethnic clinically extremely vulnerable (CEV) status each period; compare sociodemographic between different periods. Results during August October 2020 (period 2020/21; 60.4%) declined 2019/20 (62.7%) but remained above 60% Welsh standard. Variation age, deprivation, observed all periods studied. Compared pre-pandemic 2019/20, most demographic groups, except older individuals (70–74 years) those deprived group. continues be lower males, younger individuals, people living areas Asian unknown backgrounds. Conclusion Our findings are encouraging with overall achieving standard three after restarted despite disruption. Inequalities did not worsen resumed activities CRC associated remain. This needs considered targeting strategies improve informed choice avoid exacerbating disparities outcomes as services recover pandemic.

Language: Английский

---